US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 33.200
  • -1.170-3.40%
Close May 29 16:00 ET
  • 33.200
  • 0.0000.00%
Post 16:10 ET
1.09BMarket Cap13.23P/E (TTM)

About Collegium Pharmaceutical Company

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Company Profile

SymbolCOLL
Company NameCollegium Pharmaceutical
Listing DateMay 7, 2015
Issue Price12.00
Founded2002
CEOMr. Michael T. Heffernan, R.Ph.
MarketNASDAQ
Employees197
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Technology Center Drive,Suite 300
CityStoughton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02072
Phone1-781-713-3699
Websitehttp://www.collegiumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael T. Heffernan, R.Ph.
  • Chairman of the Board, Interim President and Chief Executive Officer
  • 330.61K
  • Shirley R. Kuhlmann
  • Executive Vice President, General Counsel, Secretary and Chief Administrative Officer
  • 2.87M
  • Colleen Tupper
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 2.73M
  • Scott Dreyer
  • Executive Vice President and Chief Commercial Officer
  • 2.61M
  • Dr. Thomas B. Smith, M.D.
  • Executive Vice President and Chief Medical Officer
  • 2.04M
  • Gino Santini
  • Lead Independent Director
  • 322.61K
  • Neil F. McFarlane, M.S.
  • Independent Director
  • 280.61K
  • Garen G. Bohlin
  • Independent Director
  • 299.61K
  • Gwen A. Melincoff
  • Independent Director
  • 275.61K
  • Dr. Rita Balice-Gordon, PhD
  • Independent Director
  • 275.61K
  • Dr. John A. Fallon, M.D.
  • Independent Director
  • 289.61K
  • Dr. John G. Freund,M.D.
  • Independent Director
  • 298.61K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg